Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

202 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Blood-brain barrier and chemotherapeutic treatment of brain tumors.
de Vries NA, Beijnen JH, Boogerd W, van Tellingen O. de Vries NA, et al. Among authors: van tellingen o. Expert Rev Neurother. 2006 Aug;6(8):1199-209. doi: 10.1586/14737175.6.8.1199. Expert Rev Neurother. 2006. PMID: 16893347 Review.
Phase I study of vintriptol, a tryptophan ester of vinblastine.
Oosterkamp HM, Vlasveld LT, Wanders J, Beijnen JH, van Tellingen O, Dubbelman AC, Simonetti GP, Franklin HR, Vermorken JB, Ten Bokkel Huinink WW. Oosterkamp HM, et al. Among authors: van tellingen o. Eur J Cancer. 1991;27(10):1222-6. doi: 10.1016/0277-5379(91)90085-r. Eur J Cancer. 1991. PMID: 1835590 Clinical Trial.
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs.
Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CA, van der Valk MA, Robanus-Maandag EC, te Riele HP, et al. Schinkel AH, et al. Among authors: van deemter l, van tellingen o, van der valk ma. Cell. 1994 May 20;77(4):491-502. doi: 10.1016/0092-8674(94)90212-7. Cell. 1994. PMID: 7910522
202 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page